2012
DOI: 10.1212/wnl.0b013e31826b951e
|View full text |Cite
|
Sign up to set email alerts
|

Age- and sex-specific rates of leukoaraiosis in TIA and stroke patients

Abstract: Objective: To determine any sex differences in age-specific prevalence or severity of leukoaraiosis, a marker of white matter ischemia, in population-based and clinic cohorts of TIA/stroke and in a systematic review of the literature.Methods: Age-specific sex differences were calculated for both CT and MRI in the Oxford Vascular Study (OXVASC) and in an MRI-based clinic cohort. We pooled odds ratios (ORs) for leukoaraiosis in women vs men from published studies by fixed-effect meta-analysis, stratified by pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

9
77
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 73 publications
(87 citation statements)
references
References 32 publications
(22 reference statements)
9
77
0
1
Order By: Relevance
“…Leukoaraiosis may represent a viable biomarker because it can be determined by standard neuroimaging and has been consistently shown to predict a higher risk for poor poststroke outcome. [5][6][7][8]15,18 How leukoaraiosis contributes to worse poststroke outcomes Functional improvement of patients who were alive at the time of discharge (n ϭ 87) according to leukoaraiosis severity (unadjusted). Compared with patients with absent-to-moderate leukoaraiosis, patients with severe leukoaraiosis are significantly less likely to have any improvement on the mRS from discharge to 90 days (50% versus 79% of surviving patients [21% versus 59% of all patients, respectively]; P ϭ .034; darker shades indicate less improvement).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Leukoaraiosis may represent a viable biomarker because it can be determined by standard neuroimaging and has been consistently shown to predict a higher risk for poor poststroke outcome. [5][6][7][8]15,18 How leukoaraiosis contributes to worse poststroke outcomes Functional improvement of patients who were alive at the time of discharge (n ϭ 87) according to leukoaraiosis severity (unadjusted). Compared with patients with absent-to-moderate leukoaraiosis, patients with severe leukoaraiosis are significantly less likely to have any improvement on the mRS from discharge to 90 days (50% versus 79% of surviving patients [21% versus 59% of all patients, respectively]; P ϭ .034; darker shades indicate less improvement).…”
Section: Discussionmentioning
confidence: 99%
“…2 While numerous studies have focused on procedural aspects, treatment window, and neuroimaging signatures of acute tissue injury, little is known regarding the potential contribution of preexisting white matter rarefaction (leukoaraiosis) on outcome. [3][4][5] Yet, leukoaraiosis is frequently encountered in the elderly 6,7 and is well-known to contribute to worse outcomes after acute ischemic stroke. 7,8 Given the expected tripling of the number of persons aged 60 or older in developed nations by 2050 9 and the increasing prevalence of stroke with advancing age, 10,11 it is expected that an increasing number of patients with pre-existing leukoaraiosis will be treated with EST.…”
mentioning
confidence: 99%
“…12,27,28 Because it appears that WM damage in normal elderly subjects tends to be frontal in predominance regardless of sex, 12,29 this may explain why we found women to have a higher burden of frontal WMH. Alternatively, sex-based differences in WMH burden may be the result of premature death in men with high WMH burden.…”
mentioning
confidence: 87%
“…Alternatively, sex-based differences in WMH burden may be the result of premature death in men with high WMH burden. 28 Thus, further well-designed pathophysiologic and population-based studies are required to more definitely address this issue.…”
mentioning
confidence: 99%
“…Moreover, markers of small vessel disease on brain imaging were prospectively coded in OXVASC and have been published previously. 18 The Age-Related White Matter Changes (ARWMC) scale was applied for both CT and MRI, rating 5 different regions in both hemispheres according to a 0-3 score. Total score was categorized as absent (0), mild (1-5), moderate (6-10), or severe (.10) white matter disease (WMC).…”
mentioning
confidence: 99%